Keith Wilson

From left, Qi Liu, PhD, Lori Coburn, MD, Gregor Neuert, PhD, Keith Wilson, MD, Ken Lau, PhD, and Bennett Landman, PhD, are leading VUMC’s contribution to the “gut cell atlas” program funded by the Leona M. and Harry B. Helmsley Charitable Trust.

Grant spurs effort to map biology of Crohn’s disease

VUMC has been awarded a three-year, $3 million grant to map — in unprecedented detail — the biology of Crohn’s disease.

Cancer prevention drug also disables H. pylori bacterium

A medicine currently being tested as a chemoprevention agent for multiple types of cancer has more than one trick in its bag when it comes to preventing stomach cancer, Vanderbilt researchers have discovered.

Three faculty members elected to Association of American Physicians

The Association of American Physicians (AAP) is an honorary medical society founded in 1885 by Sir William Osler and six other physicians for “the advancement of scientific and practical medicine.” This year, 60 additional physician scientists were elected to the association, including three Vanderbilt faculty members.

New target for colorectal cancer

Vanderbilt investigators have discovered that activated epidermal growth factor receptor may be a target for therapies to prevent colorectal cancer development.

New target for chronic infection

An enzyme in macrophage immune cells may be a good target for treating chronic infections, Vanderbilt researchers have discovered.

firefighters battle a wildfire

EGF receptor found to regulate macrophage inflammation in gut

Researchers at Vanderbilt University School of Medicine have uncovered a link between epidermal growth factor receptor (EGFR) signaling and the inflammatory response to bacterial infection in the gastrointestinal tract.